• Mashup Score: 2

    Over 25,000 synthesized experiments identify effective land management practices, such as tree planting and biochar use, that partially mitigate land-use change effects. Yet, indirect climate change effects still pose a potential severe threat to SOC globally

    Tweet Tweets with this article
    • Researchers from @Cirad, @GlobAgronomy inc. @RemiCardinael identify effective #landmanagement practices that partially mitigate land-use change effects. Yet, indirect #ClimateChange effects still pose a potential severe threat to #SOC globally https://t.co/QocIopIESl https://t.co/VWIiqy1ilO

  • Mashup Score: 0

    In this study, the researchers evaluated the use of standard of care (SOC) ciltacabtagene autoleucel in a patient population and compared it to the outcomes observed in the CARTITUDE-1 clinical trial. They found that a significant percentage of patients (57%) in the study population would have been ineligible for pa…

    Tweet Tweets with this article
    • 📢 ASCO 2023 🎉 🌟 #DorisHansenMD, from @MoffittNews, emphasized the need for further investigation into the impact of prior #BCMA exposure and outcomes. 🔬 The evaluation of #SOC #ciltacel in pts and compared to outcomes of the #CARTITUDE1 trial. 🔗 https://t.co/fSKJ02Rxp9 https://t.co/WE6W89dXMO

  • Mashup Score: 0

    Axi-cel: Zuma 7 was a randomized phase 3 study Zuma 7 was a randomized phase three study that used Axi-Cel versus a standard of. Care chemotherapy followed by autologous transplant.In a second line setting for most patients with relapsed refractory large B-cell lymphoma. That means adult patient with relapse refractory large B-cell lymphoma being refractory to the first line therapy or relapse…

    Tweet Tweets with this article
    • Axi-Cel: Large B-Cell Lymphoma ZUMA-7 Armin Ghobadi - ASH 2022 - How Will This Help With the Standard of Care (SOC) in Pts with Large B-Cell Lymphoma? @WUSTLmed #ASH22 #LBCL #SOC #2L #ZUMA7 Watch and Share the Video Here: https://t.co/Rn36FQve0k https://t.co/IqEF0oBhqe

  • Mashup Score: 0

    iFrame is not supported! Axi-cel: Zuma 7 was a randomized phase three study Zuma 7 was a randomized phase three study that used Axi-Cel versus a standard of. Care chemotherapy followed by autologous transplant.In a second line setting for most patients with relapsed refractory large B-cell lymphoma. That means adult patient with relapse refractory large B-cell lymphoma being refractory to the…

    Tweet Tweets with this article
    • Axi-Cel: Large B-Cell Lymphoma ZUMA-7 Armin Ghobadi - ASH 2022 - How Will This Help With the Standard of Care (SOC) in Pts with Large B-Cell Lymphoma? @WUSTLmed #ASH22 #LBCL #SOC #2L #ZUMA7 Read and Share the Article Here: https://t.co/QCdLH4BdQQ https://t.co/Y4vcCWoV5I

  • Mashup Score: 2

    Evolve Network Services Converged NOC Services Radisys offers its converged, highly available, redundant NOC/Security Operations Center (SOC) facilities and multi-tiered Network Operations Support Services complete with plug & play systems.  The integrated NOC operations support HetNet Radio Access Networks, FTTx, backhaul Transport network(IP/MPLS),…

    Tweet Tweets with this article
    • - @Radisys offers its converged, highly available, redundant #NOC #Security Operations Center #SOC facilities and multi-tiered Network Operations Support Services complete with plug & play systems. https://t.co/H59EtlpTgU #CISO #CSO #cybersecurity #CIO https://t.co/21ph3PncBH

  • Mashup Score: 0

    A study in the Journal of Drugs in Dermatology gathered a panel of skin of color experts to examine acne treatment in patients with skin of color.

    Tweet Tweets with this article
    • A study in the Journal of Drugs in Dermatology gathered a panel of skin of color experts to examine #acne treatment in patients with skin of color. #SOC https://t.co/pOlUvtEF8L https://t.co/BUNcYHqyqa

  • Mashup Score: 3

    Patients of color make up a growing market for aesthetic dermatology. Physicians must learn how to tailor treatments and assess skin of color risk to best serve this emerging patient population. Doing so will deliver positive outcomes and drive patient satisfaction.

    Tweet Tweets with this article
    • Patients of color make up a growing market for aesthetic dermatology. Physicians must learn how to tailor treatments and assess #SOC risk to best serve this emerging patient population. https://t.co/u7rF35M2ML #AADVMX2021 https://t.co/4AJWYkplG6